In conclusion, this is the first report describing the clinical features and treatment outcomes of a Chinese patient with BBSOAS and demonstrating the pathogenic nature of the NR2F1 variant. This evidence concerns the gene NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome.